Kenichiro Ito, Chairman and CEO DENSO International America Inc.; Shawn Slusser, VP, Automotive division, Infineon Americas; Mike Koeske, Senior Sales Engineer, Infineon Americas; Mike Winkler, VP DENSO North America Purchasing Group (from left) Kenichiro Ito, Chairman and CEO DENSO International America Inc.; Shawn Slusser, VP, Automotive division, Infineon Americas; Mike Koeske, Senior Sales Engineer, Infineon Americas; Mike Winkler, VP DENSO North America Purchasing Group (from left)
Munich, Germany – 19 June 2017 – The Japanese automotive system supplier DENSO has honored Infineon with a “Supplier of the Year Award”. DENSO acknowledged the Infineon North America team for their outstanding local support. The award is given to the supplier who demonstrates commitment to exceptional quality and logistics performance. The assessment criteria also include collaboration in advancing automotive technologies and the supplier’s willingness to consistently exceed expectations.
Shawn Slusser, Vice President of the Automotive division at Infineon Technologies Americas Corp., accepted the award on behalf of Infineon during a recent ceremony in Novi, Michigan, USA: “We feel honored to receive DENSO’s award for premium customer service,” said Slusser. “We consider it recognition of our growing global partnership and our global support. With a combination of deep application and system know-how, great products and local support, Infineon is committed to helping our customers to grow their business.”
Photo:
Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…
The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…
More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…
The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…
Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…
This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…